AVIR

Atea Pharmaceuticals, Inc. - common stock (AVIR)

About Atea Pharmaceuticals, Inc. - common stock (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high
$4.35
Daily low
$4.12
Price at open
--
52 Week High
$6.45
52 Week Low
$2.87
Market cap
345.7M
Dividend yield
-
Volume
27
Avg. volume
311,396
P/E ratio
-2.06

Atea Pharmaceuticals, Inc. - common stock News

Details

Daily high
$4.35
Daily low
$4.12
Price at open
--
52 Week High
$6.45
52 Week Low
$2.87
Market cap
345.7M
Dividend yield
-
Volume
27
Avg. volume
311,396
P/E ratio
-2.06